These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 14623169)
41. Comparative pulmonary toxicity inhalation and instillation studies with different TiO2 particle formulations: impact of surface treatments on particle toxicity. Warheit DB; Brock WJ; Lee KP; Webb TR; Reed KL Toxicol Sci; 2005 Dec; 88(2):514-24. PubMed ID: 16177240 [TBL] [Abstract][Full Text] [Related]
42. Pulmonary availability of isotretinoin in rats after inhalation of a powder aerosol. Raleigh SM; Verschoyle RD; Bowskill C; Pastorino U; Staniforth JN; Steele F; Dinsdale D; Carthew P; Lim CK; Silvester J; Gescher A Br J Cancer; 2000 Oct; 83(7):935-40. PubMed ID: 10970697 [TBL] [Abstract][Full Text] [Related]
43. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761 [TBL] [Abstract][Full Text] [Related]
44. Study on the Pulmonary Delivery System of Apigenin-Loaded Albumin Nanocarriers with Antioxidant Activity. Pápay ZE; Kósa A; Böddi B; Merchant Z; Saleem IY; Zariwala MG; Klebovich I; Somavarapu S; Antal I J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):274-288. PubMed ID: 28282259 [TBL] [Abstract][Full Text] [Related]
45. Recent advances in pulmonary drug delivery using large, porous inhaled particles. Edwards DA; Ben-Jebria A; Langer R J Appl Physiol (1985); 1998 Aug; 85(2):379-85. PubMed ID: 9688708 [TBL] [Abstract][Full Text] [Related]
46. Use of functional respiratory imaging to characterize the effect of inhalation profile and particle size on lung deposition of inhaled corticosteroid/long-acting β2-agonists delivered via a pressurized metered-dose inhaler. Van Holsbeke C; De Backer J; Vos W; Marshall J Ther Adv Respir Dis; 2018; 12():1753466618760948. PubMed ID: 29499614 [TBL] [Abstract][Full Text] [Related]
47. Chelation therapy of manganese intoxication with para-aminosalicylic acid (PAS) in Sprague-Dawley rats. Zheng W; Jiang YM; Zhang Y; Jiang W; Wang X; Cowan DM Neurotoxicology; 2009 Mar; 30(2):240-8. PubMed ID: 19150464 [TBL] [Abstract][Full Text] [Related]
48. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs. Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108 [TBL] [Abstract][Full Text] [Related]
49. Pharmacokinetics of antituberculosis medications delivered via percutaneous gastrojejunostomy tube. Reid J; Marciniuk D; Peloquin CA; Hoeppner V Chest; 2002 Jan; 121(1):281-4. PubMed ID: 11796464 [TBL] [Abstract][Full Text] [Related]
50. Development of porous particles using dextran as an excipient for enhanced deep lung delivery of rifampicin. Kadota K; Yanagawa Y; Tachikawa T; Deki Y; Uchiyama H; Shirakawa Y; Tozuka Y Int J Pharm; 2019 Jan; 555():280-290. PubMed ID: 30471373 [TBL] [Abstract][Full Text] [Related]
51. Formulation and in vivo evaluation of sodium alendronate spray-dried microparticles intended for lung delivery. Cruz L; Fattal E; Tasso L; Freitas GC; Carregaro AB; Guterres SS; Pohlmann AR; Tsapis N J Control Release; 2011 Jun; 152(3):370-5. PubMed ID: 21396412 [TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetics of Second-Line Antituberculosis Drugs after Multiple Administrations in Healthy Volunteers. Park SI; Oh J; Jang K; Yoon J; Moon SJ; Park JS; Lee JH; Song J; Jang IJ; Yu KS; Chung JY Antimicrob Agents Chemother; 2015 Aug; 59(8):4429-35. PubMed ID: 25987620 [TBL] [Abstract][Full Text] [Related]
53. Oxidative injury in the lungs of neonatal rats following short-term exposure to ultrafine iron and soot particles. Zhong CY; Zhou YM; Smith KR; Kennedy IM; Chen CY; Aust AE; Pinkerton KE J Toxicol Environ Health A; 2010; 73(12):837-47. PubMed ID: 20391124 [TBL] [Abstract][Full Text] [Related]
54. Ultra-fast absorption of amorphous pure drug aerosols via deep lung inhalation. Rabinowitz JD; Lloyd PM; Munzar P; Myers DJ; Cross S; Damani R; Quintana R; Spyker DA; Soni P; Cassella JV J Pharm Sci; 2006 Nov; 95(11):2438-51. PubMed ID: 16886198 [TBL] [Abstract][Full Text] [Related]
55. Quantitative morphometric analysis of pulmonary deposition of aerosol particles inhaled via intratracheal nebulization, intratracheal instillation or nose-only inhalation in rats. Leong BK; Coombs JK; Sabaitis CP; Rop DA; Aaron CS J Appl Toxicol; 1998; 18(2):149-60. PubMed ID: 9570698 [TBL] [Abstract][Full Text] [Related]
56. PEG-PLGA based large porous particles for pulmonary delivery of a highly soluble drug, low molecular weight heparin. Patel B; Gupta V; Ahsan F J Control Release; 2012 Sep; 162(2):310-20. PubMed ID: 22800582 [TBL] [Abstract][Full Text] [Related]
59. Inhaled microparticles of antitubercular antibiotic for in vitro and in vivo alveolar macrophage targeting and activation of phagocytosis. Parikh R; Dalwadi S; Aboti P; Patel L J Antibiot (Tokyo); 2014 May; 67(5):387-94. PubMed ID: 24569669 [TBL] [Abstract][Full Text] [Related]
60. A novel method to aerosolize powder for short inhalation exposures at high concentrations: isolated rat lungs exposed to respirable diesel soot. Gerde P; Ewing P; Låstbom L; Ryrfeldt A; Waher J; Lidén G Inhal Toxicol; 2004 Jan; 16(1):45-52. PubMed ID: 14744664 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]